7 December 2022 · Crushing or dispersing whole solid dosage forms or opening capsules is an "off-label" use. This includes use for Group A streptococcal infections.
30 October 2020 · Topical preparations for acne are considered to pose a negligible risk to a breastfeeding infant as long as precautions are taken to avoid contact of…
22 October 2020 · This updated Medicines Q&A evaluates the available evidence for the use of erythromycin as a prokinetic agent in adults Summary The ideal prokinetic dose of…
21 October 2020 · Epidemiologic evidence indicates that the risk of hypertrophic pyloric stenosis in infants might be increased by use of maternal macrolides, especially in infants exposed in…
2 October 2020 · This updated Medicines Q&A evaluates the evidence for an interaction between erythromycin and statins. Summary: Erythromycin raises the plasma levels of statins which are metabolised…